Morningstar

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

IRVINE, Calif., Sept. 9, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of "The One & Only" campaign, a ...
The Financial

Allergan’s BOTOX Vista Receives National Marketing Authorisation In Japan

The FINANCIAL — Allergan plc on May 23 announced that the Japanese Ministry of Health, Labour and Welfare has approved an additional use for BOTOX Vista (Allergan’s botulinum toxin type A product) as ...
Orange County Business Journal

Allergan: Ready, Realistic About Botox Rival

Competition has arrived for Irvine-based Allergan Inc.? blockbuster wrinkle-remover Botox, but Chief Executive David Pyott plans few changes in his marketing of the drug. At the end of April, Allergan ...
Reuters

Allergan says Botox works on chronic migraines

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...
Business Insider

Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines

–All primary and secondary endpoints were met for both Phase 3 studies (M21-500 and M21-508). –Results support BoNT/E as a novel botulinum neurotoxin serotype E characterized by a rapid onset of ...
Reuters

Allergan beats forecasts, but Botox sales fall

NEW YORK, July 31 (Reuters) - Allergan Inc posted a 23 percent rise in second-quarter earnings Friday, topping Wall Street expectations, as lower research and development spending helped offset ...
The Korea Herald

Medytox CEO to meet Allergan to discuss start of phase 3 trials of Innotox

Medytox CEO Jung Hyun-ho is slated to meet with executives at Allergan to discuss the start of phase 3 clinical trials of its liquid-type botulinum toxin Innotox this week, according to local news ...
Nasdaq

Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025

Allergan Aesthetics Medical Symposium Mastering the Lower Face and NeckOn Friday January 31, 2025, Dr. Alexandre Marchac, Dr. Karim Sayed, Dr. Patricia Ogilvie and Dr. Sylwia Lipko-Godlewska will ...
Orange County Business Journal

Allergan Plans Irvine Lab Expansion

Allergan Inc. plans to build a laboratory on its Irvine campus to make small quantities of neurotoxin, a component used in its flagship anti-wrinkle drug Botox. The drug maker plans to keep production ...
Morningstar

BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project

IRVINE, Calif., July 22, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: ...
Seeking Alpha

Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence

- A total of 17 abstracts, including three accepted for presentation in the Cosmetic "Top Ten" Session, underscore Allergan Aesthetics' global industry leadership across multiple aesthetic categories ...